ondansetron has been researched along with Urogenital Neoplasms in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Urogenital Neoplasms: Tumors or cancer of the UROGENITAL SYSTEM in either the male or the female.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Ondansetron was given either before or after cisplatin to control nausea and vomiting." | 5.09 | Cisplatin-induced vomiting depends on circadian timing. ( Fujimura, A; Kobayashi, E; Kobayashi, M; To, H; Tokue, A, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, M | 1 |
| To, H | 1 |
| Tokue, A | 1 |
| Fujimura, A | 1 |
| Kobayashi, E | 1 |
1 trial available for ondansetron and Urogenital Neoplasms
| Article | Year |
|---|---|
Cisplatin-induced vomiting depends on circadian timing.
Topics: Acetylglucosaminidase; Adult; Aged; Antiemetics; Antineoplastic Agents; Blood Urea Nitrogen; Chronot | 2001 |